Literature DB >> 16635440

Endothelial function and cerebrovascular disease: implications for diagnosis and treatment.

Ahmad A Elesber1, Piero O Bonetti, Amir Lerman.   

Abstract

Cerebrovascular disease remains one of the most common causes of morbidity and mortality in the United States. There is strong evidence to implicate endothelial dysfunction in the initiation and progression of atherosclerosis and its complications. It is now well known that endothelial dysfunction represents a systemic syndrome involving multiple vascular beds, including the cerebral vasculature. Currently, no gold standard treatment for endothelial dysfunction exists. Nonetheless, several treatment strategies have been found to be helpful in improving endothelial function. A few of these strategies have been implicated in stroke risk reduction as well, adding another line of evidence to the relationship between endothelial function and cerebrovascular disease.

Entities:  

Year:  2006        PMID: 16635440     DOI: 10.1007/s11936-006-0014-x

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  55 in total

1.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

2.  Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association.

Authors:  Harold Adams; Robert Adams; Gregory Del Zoppo; Larry B Goldstein
Journal:  Stroke       Date:  2005-04       Impact factor: 7.914

3.  Randomized trial of a medical food for the dietary management of chronic, stable angina.

Authors:  Andrew J Maxwell; Michael P Zapien; Greg L Pearce; Gail MacCallum; Peter H Stone
Journal:  J Am Coll Cardiol       Date:  2002-01-02       Impact factor: 24.094

4.  Role of angiotensin II type 1 receptor in the regulation of cellular adhesion molecules in atherosclerosis.

Authors:  A Prasad; K K Koh; W H Schenke; R Mincemoyer; G Csako; T A Fleischer; M Brown; T A Selvaggi; A A Quyyumi
Journal:  Am Heart J       Date:  2001-08       Impact factor: 4.749

5.  Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month.

Authors:  G O'Driscoll; D Green; R R Taylor
Journal:  Circulation       Date:  1997-03-04       Impact factor: 29.690

Review 6.  The role of natural antioxidants in preserving the biological activity of endothelium-derived nitric oxide.

Authors:  A Carr; B Frei
Journal:  Free Radic Biol Med       Date:  2000-06-15       Impact factor: 7.376

7.  Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke.

Authors:  Mushfiquddin Khan; Bipanjeet Sekhon; Manu Jatana; Shailendra Giri; Anne G Gilg; Charanpal Sekhon; Inderjit Singh; Avtar K Singh
Journal:  J Neurosci Res       Date:  2004-05-15       Impact factor: 4.164

8.  Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.

Authors:  James F Toole; M René Malinow; Lloyd E Chambless; J David Spence; L Creed Pettigrew; Virginia J Howard; Elizabeth G Sides; Chin-Hua Wang; Meir Stampfer
Journal:  JAMA       Date:  2004-02-04       Impact factor: 56.272

9.  Prospective study of major dietary patterns and stroke risk in women.

Authors:  Teresa T Fung; Meir J Stampfer; JoAnn E Manson; Kathryn M Rexrode; Walter C Willett; Frank B Hu
Journal:  Stroke       Date:  2004-07-01       Impact factor: 7.914

Review 10.  An imbalance in antioxidant defense affects cellular function: the pathophysiological consequences of a reduction in antioxidant defense in the glutathione peroxidase-1 (Gpx1) knockout mouse.

Authors:  Judy B De Haan; Peter J Crack; Nicole Flentjar; Rocco C Iannello; Paul J Hertzog; Ismail Kola
Journal:  Redox Rep       Date:  2003       Impact factor: 4.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.